| ¿µ¹® | Minnesota Multiphasic Personality Inventory(MMPI) | ÇÑ±Û | ¹Ì³×¼ÒŸ ´Ù¸éÀû Àμº°Ë»ç |
|---|---|---|---|
| ¼³¸í | °´°üÀû Àΰݰ˻翡 ÀÌ¿ëÇÏ´Â °Ë»ç¹æ¹ýÀ¸·Î ºñ±³Àû ½Ç½Ã¿Í äÁ¡ÀÌ °£´ÜÇÏÁö¸¸, ÀÓ»óÀû ÇØ¼®°ú Àû¿ë¿¡´Â Àü¹®¼ºÀÌ ¿ä±¸µÇ´Â °Ë»çÀÌ´Ù. ÀÌ ¹æ¹ýÀº ÁÖ¾îÁø 556°³ÀÇ ¹®Ç׸¶´Ù ±×·¸´Ù, ¸ð¸£°Ú´Ù, ȤÀº ¾Æ´Ï´Ù·Î ´ë´äÇÏ°Ô ÇÑµÚ 3°³ÀÇ ½Å·Ú¼ºÃ´µµ¿Í 10°³ÀÇ ÀÓ»óôµµ¿¡ ´ëÇØ Á¶»çÇÑ´Ù. |
||
| ¿µ¹® | Dilatation and Curettage(D & C) | ÇÑ±Û | Àڱñܾ¼ú, ÀڱøñÈ®Àå |
|---|---|---|---|
| ¼³¸í | ÀÚ±ÃÀ̶õ žư¡ ¼öÅÂµÇ¾î¼ ºÐ¸¸Àü±îÁö ¹ßÀ°ÇÏ°í ¼ºÀåÇÏ´Â °ø°£ÀÌ´Ù. Àڱüӿ¡ º´º¯ÀÌ ÀÖ¾î ÀÓ½ÅÀÌ °è¼ÓµÉ ¼ö ¾ø°Å³ª ¾Æ´Ï¸é ´Ù¸¥ ÀÌÀ¯·Î ÀӽŵǾî Àִ žƸ¦ Á¦°ÅÇϰíÀÚ ÇÒ °æ¿ì¿¡ »ç¿ëµÇ´Â ¹æ¹ýÀÌ´Ù. ¿©±â¼ ±Ü¾î³»±â À§ÇÏ¿©´Â ¿ì¼± ÀÚ±ÃÀÇ ÀÔ±¸¿¡ ÇØ´çÇÏ´Â ÀڱøñÀ» È®Àå½ÃÄÑ¾ß ÇÑ´Ù. ¿©±â¿¡´Â ±Þ¼ÓÈ÷ È®ÀåÀ» ½ÃµµÇÏ´Â ¹ý°ú ¼¼È÷ È®ÀåÀ» ½ÃµµÇÏ´Â 2°¡Áö ¹æ¹ýÀÌ ÀÖ´Ù. ÀڱøñÀ» ±Þ¼ÓÈ÷ È®ÀåÇÒ ¶§´Â Çì°¡¸£ ¸ñ°üÈ®Àå±â(Hegar's dilatator)¸¦ »ç¿ëÇÑ´Ù. À̰ÍÀº ÀÛÀº ±Ý¼Ó¸·´ë·Î ÀÛÀº Å©±âºÎÅÍ Å« Å©±â±îÁö ´Ù¾çÇÑ Å©±â°¡ ÀÖ¾î¼ ¿ì¼± ÀÛÀº ¸·´ë·Î ½ÃÀÛÇÏ¿© Á¡Á¡ Å« Å©±âÀÇ ¸·´ë¸¦ Àڱøñ¿¡ ³Ö¾î¼ ÀڱøñÀ» È®Àå½ÃŲ´Ù. ¼¼È÷ È®Àå½Ãų ¶§´Â Laminaria tent¸¦ ¸ñ°ü¿¡ »ðÀÔÇÏ´Â ¹æ¹ýÀ» »ç¿ëÇÑ´Ù. Laminaria tent¶õ ÇØÃÊ·Î ¸¸µç ÀÛÀº ¸·´ë·Î ¼öºÐÀ» Èí¼öÇϸé Á¡Á¡ ´Ã¾î³ª´Â ¼ºÁúÀÌ ÀÖ´Ù. À̰ÍÀ» ÀÚ±ÃÀÇ ¸ñ¿¡ ³ÖÀ¸¸é À̰ÍÀÌ ¼öºÐÀ» Èí¼öÇÏ¿© ´Ã¾î³ª¹Ç·Î õõÈ÷ ÀÚ±ÃÀÇ ¸ñÀÌ ´Ã¾î³´Ù. ÀڱøñÀÌ ÃæºÐÈ÷ ´Ã¾î³ª¸é ±× ¼ÓÀ¸·Î ³¡ÀÌ ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ ³Ö¾î¼ ÀڱüÓÀÇ º´º¯À̳ª ÀÓ½ÅµÈ Å¾Ƹ¦ ±Ü¾î³»´Âµ¥ ¿©±â¿¡ »ç¿ëµÇ´Â ¼ù°¡¶ôó·³ »ý±ä ±â±¸¸¦ Å¥·¿À̶ó°í ÇÑ´Ù. Ãʱâ ÀÓ½ÅÁßÀý Áï À¯»ê°ú °°Àº ÀӽŰú °ü·ÃµÈ °æ¿ì»Ó¸¸ ¾Æ´Ï¶ó, ºñÀӽŠÀÚ±ÃÀÇ Àڱ󻸷Á¶Á÷ÀÇ Ã¤Ãë ¹× Á¦°Å¸¦ À§Çؼµµ ÇàÇØÁö´Â ¼ö±âÀÌ´Ù. ÀÌ´Â ¿øÄ¢ÀûÀ¸·Î ¸¶ÃëÇÏ¿¡ ½Ç½ÃµÇ´Â °ÍÀ¸·Î Àڱøñ°üÀ» È®ÀåÇÏ°í ±â±¸·Î Àڱà ³»¿ë¹°À» Á¦°ÅÇϰí Å¥·¿À¸·Î Àڱ󻺮À» ±ú²ýÀÌ ÇÑ´Ù. ÀÚ±Ãõ°øÀ̳ª ÀڱøñÀÇ ÆÄ¿ µîÀÇ À§ÇèÀÌ µû¸£¸ç, ¼ö¼úÈÄ °¨¿° ¶Ç´Â ÃâÇ÷ µî¿¡ ´ëÇÑ ÁÖÀǰ¡ ÇÊ¿äÇÏ´Ù. |
||
| PBMC | peripheral blood mononuclear cell; pharmaceutical benefit management company |
|---|---|
| HIPO | hemihypertrophy, intestinal web, preauricular skin tag, and congenital corneal opacity [syndrome]; H... |
| MMPI | Minnesota Multiphasic Personality Inventory; ¹Ì³×¼ÒŸ ´Ù¸é¼º ÀÎ°Ý °Ë»ç(´Ù¸éÀû Àμº °Ë»ç) |
| MALG | Minnesota antilymphoblast globulin |
| MCDI | Minnesota Child Development Inventory |
| BI | biological indicator |
|---|---|
| MHHP | Minnesota Heart Health Program |
| MMPI | Minnesota Muliphasic Personality Inventory |
| MMPI 2 | Minnesota Multiphasic Personality Inventory |
| MMPI-2 | Minnesota Multiphasic Personality Inventory 2 |
acute angle
| microbial mining | The use of microorganisms to remove minerals, particularly metals, from rocks. See: biohydrometallurgy, leaching. (14 Nov 1997) |
|---|---|
| Minnesota Multiphasic Personality Inventory | A questionnaire type of psychological test for ages 16 and over, with 550 true-false statements coded in 4 validity and 10 personality scales which may be administered in both an individual or group format. Synonym: Minnesota Multiphasic Personality Inventory. (05 Mar 2000) |
| Minnesota multiphasic personality inventory test | A questionnaire type of psychological test for ages 16 and over, with 550 true-false statements coded in 4 validity and 10 personality scales which may be administered in both an individual or group format. Synonym: Minnesota Multiphasic Personality Inventory. (05 Mar 2000) |
| alizarin indicator | A solution consisting of 1 g sodium alizarin sulfonate dissolved in 100 cc distilled water; used as an indicator for free acidity in gastric contents. (05 Mar 2000) |
| management indicator species | A species whose habitat requirements most reflect those of the species community in the habitat of concern, usually used to indicate habitat quality and to predict future conditions. (09 Oct 1997) |
| redox indicator | A substance that undergoes a definite colour change at a specific oxidation potential. Synonym: redox indicator. (05 Mar 2000) |
| wetland indicator status | <ecology> The exclusiveness with which a plant species occurs in wetland, the different indicator categories (i.e., facultative species, and obligate wetland species) are defined elsewhere in this glossary. (09 Oct 1997) |
| health indicator | Variable, susceptible to direct measurement, that reflects the state of health of persons in a community. (05 Mar 2000) |
| indicator | An event, entity or condition that typically characterises a prescribed environment or situation, indicators determine or aid in determining whether or not certain stated circumstances exist or criteria are satisfied. (09 Oct 1997) |
| indicator-dilution curve | Graph of the serial concentrations (dilutions) of a dye, e.g., Evans blue, following its intravascular or intracardiac injection; useful in the diagnosis of congenital cardiac shunts, measurement of cardiac output, and detection of cardiovalvular incompetence. Synonym: indicator-dilution curve. (05 Mar 2000) |
| indicator dilution method | hamilton-Stewart method |
| indicator dilution techniques | Methods for assessing flow through a system by injection of a known quantity of an indicator, such as a dye, radionuclide, or chilled liquid, into the system and monitoring its concentration over time at a specific point in the system. (12 Dec 1998) |
| indicator organisms | Organisms that respond predictably to various environmental changes, and whose presence, or abundance, are used as indicators of environmental conditions. (09 Oct 1997) |
| indicator plant | Plant species indicating some specific characteristic of a certain locality. (09 Oct 1997) |
| indicator system | In in vitro immunological tests, a combination of reagents used to determine the degree to which immunological reagents have combined (e.g., sensitised erythrocytes in complement-fixation tests; enzyme and substrate in enzyme-linked immunosorbent assays). (05 Mar 2000) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|